Avalyn Pharma Invited to Present at Canaccord Genuity Annual Growth Conference

<p>SEATTLE , July 27, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of targeted therapies for life-threatening pulmonary diseases, announced that CEO Lyn Baranowski will participate in the 43rd annual Canaccord Genuity Growth Conference, which is being held August 7-10, 2023 in Boston, MA. During her scheduled fireside chat, Ms. […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/avalyn-pharma-invited-to-present-at-canaccord-genuity-annual-growth-conference/">Avalyn Pharma Invited to Present at Canaccord Genuity Annual Growth Conference</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>